BMS-1166-N-piperidine-COOH is primarily utilized in pharmaceutical research and development, particularly in the field of drug discovery. It serves as a key intermediate or building block in the synthesis of novel therapeutic agents. Its structure is often exploited in the design of compounds targeting specific biological pathways, such as enzyme inhibition or receptor modulation. This chemical is particularly valuable in the development of central nervous system (CNS) drugs due to its piperidine moiety, which is commonly found in molecules that interact with neurological targets. Additionally, it is used in the optimization of drug candidates to enhance their pharmacokinetic properties, such as bioavailability and metabolic stability. Researchers also employ it in the preparation of analogs for structure-activity relationship (SAR) studies to identify potent and selective drug candidates.